STAAR Surgical Company (STAA)
Solvency ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.27 | 1.25 | 1.23 | 1.24 | 1.25 | 1.22 | 1.24 | 1.27 | 1.32 | 1.30 | 1.25 | 1.24 | 1.31 | 1.26 | 1.25 | 1.25 | 1.30 | 1.29 | 1.29 | 1.29 |
STAAR Surgical Company's solvency ratios, based on the provided data, show consistent stability and low financial leverage over time.
The debt-to-assets ratio, debt-to-capital ratio, and debt-to-equity ratio consistently remain at 0.00, indicating that the company operates with minimal to no debt relative to its assets and capital structure.
The financial leverage ratio, on the other hand, shows slight fluctuations around 1.25 to 1.30, indicating an average leverage of 1.27 over the period. This suggests that the company is financing its operations primarily through equity rather than debt, which is generally a positive indicator of financial health and stability.
Overall, the solvency ratios reflect a strong financial position for STAAR Surgical Company, with a prudent approach to managing its debt levels and maintaining a healthy balance between debt and equity in its capital structure.
Coverage ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 2,341.42 | 1,332.57 | 1,629.12 | 1,916.06 | 2,576.59 | 3,863.15 | 4,928.11 | 7,596.40 | 5,556.50 | 2,730.27 | 1,592.82 | 640.58 | 225.63 | 129.08 | 71.14 | 145.27 | 164.61 | 184.43 | 218.20 | 387.42 |
STAAR Surgical Company's interest coverage ratio has fluctuated over the past few years. The interest coverage ratio measures the company's ability to meet its interest obligations with its earnings. A higher interest coverage ratio indicates that the company is more capable of covering its interest expenses.
Looking at the data provided, we observe a significant variability in STAAR Surgical Company's interest coverage ratio. In recent periods, the interest coverage ratio has been relatively high, indicating a strong ability to cover interest expenses. For example, as of December 31, 2023, the interest coverage ratio was reported at a very high level of 2,341.42, implying a substantial ability to cover interest payments.
However, the interest coverage ratio has shown some fluctuations, with some periods reporting lower ratios. For instance, in the first quarter of 2021, the interest coverage ratio was considerably lower at 225.63, suggesting a lower capacity to cover interest expenses at that time.
Overall, the trend in STAAR Surgical Company's interest coverage ratio shows variability, but the recent periods indicate a strong ability to fulfill interest obligations. Investors and creditors may find this data important when assessing the company's financial health and ability to manage its debt obligations.